학술논문
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)
Document Type
Article
Author
Source
In: Human Vaccines and Immunotherapeutics . (Human Vaccines and Immunotherapeutics, 2022, 18(1):1-14)
Subject
Language
English
ISSN
2164554X
21645515
21645515